After the new announcement of the formation of the advisory board, Global Trac Solutions, Inc. (PSYC) saw a significant share price spike. We are talking about double digit stock returns in a one month time period. Given the current COVID19 crisis, shareholders will most likely appreciate the stock performance. With that, let’s review a bit the new directors elected.
George Y. Salameh, Hyder A. Khoja, PhD, And Kelli Foulkroud
With more than 35 years of expertise within the medical community, Dr. Salameh also brings expertise as an entrepreneur and real estate developer. According to the company’s press release, he has collaborated with San Diego venture capitalists for the past ten years.
Dr. Khoja brings approximately 19 years of experience in molecular biology. The business profile and academic curriculum are quite impressive. Have a look at the following lines:
Dr. Khoja leverages his knowledge in drug discoveries from plant extracts and analytics to validate consistent medical-grade plant nano-molecules for therapeutics. Dr. Khoja received his doctorate (Ph.D.), in 2003 with honors in Molecular Biology and Genetic Engineering from a French Ivy league: INP-ENSAT and had his Post-doctoral training from the Michigan State University a US land grant university. Source: Press Release
The company will also count with the expertise of Kelli Foulkrod, who worked in the mental health industry for over 19 years. Notice that Kelly has a lot of experience of treating patients suffering from depression, and other traumas. Kelli will know well whether medicinal psychedelics will help these individuals:
For the past ten years, she has managed her private practice, the Organic Mental Health Center, where she has focused her expertise and energy in supporting healing in trauma and complex PTSD, pregnant and postpartum women and their families, reproductive trauma, grief and loss, psychosis, bipolar, OCD, and treatment resistant depression. Source: Press Release
Currently trading with a market capitalization of close to one million, PSYC signed a memorandum of understanding with PsycheDev. If the companies involved reach an agreement, they may announce some type of business combination. In that case, we will be expecting PSYC to raise additional capital and release higher sales expectations.
Stay tuned, we will be assessing the next steps of PSYC soon.
Disclosure: We Don’t Own Shares Of PSYC, And Were Not Paid For The Article.